Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer. | Heliyon | 2023 | 37123902 | PubTator, text mining | PubMed |
| Potential genetic therapies based on m6A methylation for skin regeneration: Wound healing and scars/keloids. | Front Bioeng Biotechnol | 2023 | 37122849 | PubTator, text mining | PubMed |
| Identification and validation of fatty acid metabolism-related lncRNA signatures as a novel prognostic model for clear cell renal cell carcinoma. | Sci Rep | 2023 | 37120692 | PubTator, text mining | PubMed |
| Genetic Modulation of BET1L Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m6A Modification. | Cancer Res | 2023 | 37115853 | PubTator, text mining | PubMed |
| Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment. | Pharmaceuticals (Basel) | 2023 | 37111316 | PubTator, text mining | PubMed |
| Identification of Metabolism-Related Proteins as Biomarkers of Insulin Resistance and Potential Mechanisms of m6A Modification. | Nutrients | 2023 | 37111057 | PubTator, text mining | PubMed |
| Alteration of m6A-Tagged RNA Profiles in Bone Originated from Periprosthetic Joint Infection. | J Clin Med | 2023 | 37109200 | PubTator, text mining | PubMed |
| An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. | Genes (Basel) | 2023 | 37107631 | PubTator, text mining | PubMed |
| Regulatory Effect of Inflammatory Mediators in Intervertebral Disc Degeneration. | Mediators Inflamm | 2023 | 37101594 | PubTator, text mining | PubMed |
| Characterization of the m6A regulator-mediated methylation modification patterns in oral squamous cell carcinoma. | Sci Rep | 2023 | 37095314 | PubTator, text mining | PubMed |
| Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. | Cell Death Dis | 2023 | 37095108 | PubTator, text mining | PubMed |
| Upregulation of UBR1 m6A Methylation by METTL14 Inhibits Autophagy in Spinal Cord Injury. | eNeuro | 2023 | 37094938 | PubTator, text mining | PubMed |
| m6A-modification regulated circ-CCT3 acts as the sponge of miR-378a-3p to promote hepatocellular carcinoma progression. | Epigenetics | 2023 | 37092305 | PubTator, text mining | PubMed |
| Endogenous neural stem cells characterization using omics approaches: Current knowledge in health and disease. | Front Cell Neurosci | 2023 | 37091923 | PubTator, text mining | PubMed |
| Exploring m6A-RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome. | Pulm Circ | 2023 | 37091123 | PubTator, text mining | PubMed |
| Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. | MedComm (2020) | 2023 | 37090117 | PubTator, text mining | PubMed |
| Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase. | ACS Chem Biol | 2023 | 37082867 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1α/NF-κB axis in psoriasis. | Cell Death Dis | 2023 | 37076497 | PubTator, text mining | PubMed |
| Identification of a m6A-related ferroptosis signature as a potential predictive biomarker for lung adenocarcinoma. | BMC Pulm Med | 2023 | 37072786 | PubTator, text mining | PubMed |
| METTL3 Mediates Epithelial-Mesenchymal Transition by Modulating FOXO1 mRNA N6 -Methyladenosine-Dependent YTHDF2 Binding: A Novel Mechanism of Radiation-Induced Lung Injury. | Adv Sci (Weinh) | 2023 | 37072646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=60